Solid Tumors
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)
- Details
ClinicalTrials.gov ID:
NCT05103358
Diagnosis Type:
NA
USOR Number:
- Address
11750 W 2nd Place, Suite 160
Lakewood, CO 80228
P: (303) 430-2700